RareResearch.AI
← Back to atlas

P320S

Category 3/4 — Most DruggableUncertain significanceTransmembrane · predictedSource card
ProlineSerine at position 320 · Transmembrane helix 1 · WFS1 (Wolframin)

Interactive 3D Structure

Wild-type reference
Wild-type P320 — hydrogen bond to H323
Fullscreen ↗
DynaMut2 mutant · P320S
Mutant S320 — hydrogen bond to I318 lost (5 contacts lost)
Fullscreen ↗

Bond changes · DynaMut2 interaction analysis

5 lost3 gained4 preserved
Interaction typeWild-type partnerMutant partnerStatus
Hydrogen bondI318Lost
Hydrogen bondH323H323Preserved
Hydrogen bondI324I324Preserved
Polar contactI318Lost
Polar contactH322Lost
Polar contactH323H323Preserved
Polar contactI324I324Preserved
Van der WaalsI318Lost
Van der WaalsH322Gained
Van der WaalsH323Gained
Van der WaalsI324Gained
HydrophobicH323Lost

Lost / gained / preserved interatomic contacts at the variant residue, from the DynaMut2 (Arpeggio) interaction analysis of the wild-type and energy-minimized mutant structures.

Computational Predictions

DynaMut2 ΔΔG
-0.24kcal/mol
Destabilising — mild
AlphaMissense
0.932
likely pathogenic
AlphaFold pLDDT
68
model confidence
Schema
Cat 3/4
Category 3/4 — Most Druggable

Clinical Evidence

ClinVar classificationUncertain significance/Uncertain risk allele
Review statuscriteria provided, multiple submitters, no conflicts
Associated conditionsWolfram syndrome 1
Population frequency (gnomAD v4)Ultra-rare · AF 0.000068%
cDNA changec.958C>T
ClinVar accessionVCV000444629
Last evaluated2017/02/01 00:00

Observed at very low frequency in gnomAD.

Full Variant Card

WFS1 Wolframin — P320S Variant Card

Molecular Atlas Pilot · RareResearch.AI · Generated by wolfram-variant-card skill

Proline → Serine at position 320. Transmembrane helix 1. ClinVar Uncertain significance/Uncertain risk allele, AlphaMissense 0.932, DynaMut2 ΔΔG -0.24 kcal/mol (destabilising).


Identity

FieldValue
VariantP320S (p.Proline320Serine)
DNA changec.958C>T
Gene · ProteinWFS1 · Wolframin (890 aa)
UniProtO76024 · WFS1_HUMAN
ClinVar accessionVCV000444629
Amino acid changeProline (P) → Serine (S)

Structural Context

FieldValue
AlphaFold modelAF-O76024-F1, v6
pLDDT at residue 32067.62 — confident
DomainTransmembrane helix 1
Position contextInside Transmembrane helix 1 · position 320 is bilayer-embedded
IDR flagNo — pLDDT above 50 threshold

UniProt features at this position:

(none catalogued)

Position 320 sits in a transmembrane helix (Transmembrane helix 1). Wolframin has eleven such helices anchoring it in the ER membrane; substitutions inside the bilayer-embedded segments can disrupt helix packing, lipid contacts, and the overall ER topology of the protein. The wild-type residue is rigid/helix-breaking (proline — kinks backbone); the mutant is small polar (serine — hydroxyl). The chemistry shift implies altered local packing, hydrogen-bonding, and/or electrostatics at this site.


Computational Predictions

AlphaMissense

FieldValue
am_pathogenicity0.9318
am_classlikely pathogenic
InterpretationLikely pathogenic (threshold 0.564)

DynaMut2

FieldValue
ΔΔG (kcal/mol)-0.24 (Destabilising)
Job ID178092103622
Result URLhttps://biosig.lab.uq.edu.au/dynamut2/results_prediction/178092103622

Clinical Evidence

FieldValue
ClassificationUncertain significance/Uncertain risk allele
Review statuscriteria provided, multiple submitters, no conflicts
Last evaluated2017/02/01 00:00
InheritanceAutosomal recessive Wolfram syndrome 1 phenotype documented.
WFS1 variant landscapeP320S is 1 of ~326 pathogenic-spectrum variants in WFS1 (out of 2,243 catalogued in ClinVar)
  • Wolfram syndrome 1

Research Path Decision Tree

ΔΔG < 2  + binding site affected   →  CATEGORY 3 — docking experiments
ΔΔG 2–4                            →  CATEGORY 2 — pharmacological chaperones
ΔΔG > 4                            →  CATEGORY 1 — gene therapy
pLDDT < 50                         →  CATEGORY 5 — IDR, experimental only
Stable fold + functional site hit  →  CATEGORY 4 — site-specific docking

Final Schema Categorization

Category 3/4 — Most Druggable

<strong>Category 3/4 — Most Druggable</strong><br/><br/>|ΔΔG|=0.24 < 2 kcal/mol (fold intact) + AlphaMissense 0.932 confirms functional impact. Specific local contacts disrupted — priority for docking and pharmacological chaperone screening.

Why this card matters. Wolframin's fold survives this substitution (|ΔΔG|=0.24 kcal/mol). The pathogenic signal is real — AlphaMissense places it at 0.932. Protein still folds, but a specific local site is broken. Pharmacological chaperones and small-molecule binders are the rational therapeutic vector.


Files in this folder

  • AF-O76024-F1-model_v6.pdb — AlphaFold structure
  • P320S_molstar_viewer.html — interactive 3D viewer (auto-highlights position 320 with ball-and-stick + neighbors within 5Å)
  • P320S_variant_card.md — this card (source of truth)
  • P320S_variant_card.html — styled printable card
  • P320S_dynamut2_summary.html — clean offline DynaMut2 result card
  • dynamut2_result.json — structured result data
  • dynamut2_result_page.html — local snapshot of the Biosig result page (asset URLs absolutized)
  • P320S_wildtype_interactions.pse / P320S_mutant_interactions.pse — PyMOL sessions

Generated by wolfram-variant-card skill · RareResearch.AI Molecular Atlas Every assumption documented. Every score sourced.

Therapeutic Strategy Handoff · prediction

Feed this card to Wolfram Intelligence

Download the P320S PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.

Download P320S PDF card ↓Strategies are AI-generated predictions, not validated therapeutics.